Results 111 to 120 of about 7,241 (205)

Supplementary Material for: A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)

, 2017
Background: Idiopathic membranous nephropathy remains the leading cause of nephrotic syndrome in Caucasian adults. Immunosuppressive therapy with cyclosporine (CSA) is often successful in reducing proteinuria, but its use is associated with a high ...
Sethi S. (4153546), Hladunewich M.A. (4153534), Canetta P.A. (3629656), Gipson D.S. (4153543), Irazabal M.V. (4153540), Fervenza F.C. (4153531), Lafayette R.A. (4147267), Aslam N. (4142122), Barbour S.J. (4153537), Rovin B.H. (4153528)   +9 more
core   +1 more source

The role of TOMM20 in Mediating TERT translocation to mitochondria and its impact on mitophagy in membranous nephropathy

BMC Nephrology
Background In idiopathic membranous nephropathy (MN)—now a leading glomerular cause of end-stage kidney disease—mitochondrial quality control via mitophagy is increasingly recognized as a determinant of podocyte fate, yet the molecular switches governing
Limiao Yang, Hongle Yang, Mingming Zhang, Feifei Zhang, Xiaomei Liu, Zhiping Zhang, Jing Wang, Xiaolu Chen, Yuexuan Wang, Rui Zhang, Weihao Li   +10 more
doaj   +1 more source

The effects of traditional Chinese botanical medicine on membranous nephropathy

Frontiers in Pharmacology
Membranous nephropathy (MN), an autoimmune glomerulopathy driven by podocyte antigens, is a leading cause of end-stage renal disease (ESRD). However, its pathogenic mechanisms remain incompletely understood.
Tong Yin, Xinyu Zhang, Jiahao Liang, Xiaoming Yan, Zepeng Li, Wenlong Li, Jingyi Li, Lianhua Li, Ming Chen   +8 more
doaj   +1 more source

A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).

, 2015
BACKGROUND: Idiopathic membranous nephropathy remains the leading cause of nephrotic syndrome in Caucasian adults. Immunosuppressive therapy with cyclosporine (CSA) is often successful in reducing proteinuria, but its use is associated with a high ...
Brenchley, Paul; id_orcid, Greene, Eddie L, Reich, Heather N, Appel, Gerald B, Brenchley, Paul, Jefferson, J. Ashley, Juncos, Luis A, Jefferson, J Ashley, Gipson, Debbie S, Fervenza, Fernando C, Lieske, John C, Cattran, Daniel C, Blumenthal, Samuel S, Sussman, Amy N, Canetta, Pietro A, McCarthy, Ellen T, Leung, Nelson, Gipson, Patrick E, Barbour, Sean J, Hladunewich, Michelle A, Philibert, David, Hogan, Marie C, Kretzler, Matthias, Simon, James, Rizk, Dana V, Irazabal, Maria V, Sethi, Sanjeev, Sedor, John R, Mentor Consortium Grp, Radhakrishnan, Jai, Aslam, Nabeel, Green, Dollie F, Dillon, John J, Thomas, Leslie F, Rovin, Brad H, Hebert, Lee A, Eirin, Alfonso, Lasic, Lada B, Lafayette, Richard A   +38 more
core   +1 more source

[Antiphospholipid antibodies in idiopathic membranous nephropathy].

Revista medica de Chile, 2005
1
Ardiles, L, Blackburn, E, Alruiz, P, Flores, C, Mezzano, S   +4 more
openaire   +3 more sources

Idiopathic membranous nephropathy with focal segmental sclerosis

Терапевтический архив
Aim. To evaluate the clinical and pathological features and prognosis of idiopathic membranous nephropathy (IMN) with focal segmental sclerosis (FSGS) in a group of Russian patients. Materials and methods.
Elena S. Kamyshova, Irina N. Bobkova, Patimat А. Kakhsurueva, Amnat S. Abdulaeva, Tatiana Е. Rudenko, Ekaterina V. Stavrovskaya, Elena Yu. Andreeva, Olga А. Li, Aleksandr Yu. Suvorov   +8 more
doaj   +1 more source

Rituximab use in adult primary glomerulopathy: where is the evidence?

Therapeutics and Clinical Risk Management, 2016
Samir G Mallat,1 Houssam S Itani,2 Rana M Abou-Mrad,3 Rima Abou Arkoub,4 Bassem Y Tanios1 1Division of Nephrology, Department of Internal Medicine, American University of Beirut Medical Center, 2Division of Nephrology, Department of Internal Medicine ...
Mallat SG, Itani HS, Abou-Mrad RM, Abou Arkoub R, Tanios BY   +4 more
doaj  

An Evaluation of the Level of Anti-phospholipase A2 Receptor (PLA2R) Antibody in Different Pathological Types of Glomerulonephritis

Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, 2017
BACKGROUND AND OBJECTIVE: Nowadays, anti-phospholipase A2 receptor (PLA2R) antibody is recognized as a diagnostic biomarker for idiopathic membranous nephropathy (iMN) and is also used to assess disease progression.
F Sadadi, E Taherkhani, Sh Ossareh, T Shoshtarizadeh, HR Khoddami Vishteh   +4 more
doaj  

Treatment of Idiopathic Membranous Nephropathy [PDF]

Nephron, 2008
openaire   +2 more sources

Optimizing the treatment of idiopathic membranous nephropathy. [PDF]

, 2005
Contains fulltext : 27028.pdf (Publisher’s version ) (Open Access)Idiopathic membranous nephropathy (iMN) is a common cause of the nephrotic syndrome in adults.
Buf-Vereijken, P.W.G. du
core